Daunomycin administered by continuous intravenous infusion is effective in the treatment of acute nonlymphocytic leukaemia

Jerry P. Lewis,F. Meyers,Leora Tanaka
DOI: https://doi.org/10.1111/j.1365-2141.1985.tb02824.x
1985-10-01
British Journal of Haematology
Abstract:Summary. Anthracyclines given by continuous infusion, as opposed to bolus administration, are associated with a reduced incidence of cardiac and gastrointestinal toxicity. Our study was developed to test the antileukaemic effect of anthracyclines given as a continuous infusion. Nineteen sequential patients admitted for treatment of acute nonlymphocytic leukaemia (ANLL) were managed with a regimen utilizing a 3 d continuous intravenous infusion of daunomycin (DNM), and the complete response rate was similar to this institution's past experience with antileukaemic regimens employing 3 d bolus DNM. In our studies, infusion DNM was at least as myelotoxic and antileukaemic as bolus DNM; thus this method of administration should be explored further in remission‐induction regimens for ANLL.
What problem does this paper attempt to address?